ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 96
  • Next Page »
Search Again »
  • Abstract Number: 2241 • ACR Convergence 2023

    Guselkumab Efficacy in Active Psoriatic Arthritis Patients with or Without Hyperuricemia: Post-hoc Analysis of Two Phase 3, Randomized, Double-blind, Placebo-Controlled Studies

    Renaud FELTEN1, Laura Widawski2, Lionel Spielman2, Jacques-Eric Gottenberg3, Pierre-Marie Duret2, Emmanouil Rampakakis4, Mohamed Sharaf5, Caren Constantin6, vincenza campana6 and Laurent Messer7, 1Hôpital de Hautepierre, Strasbourg, France, 2Hôpitaux civils de Colmar, Colmar, France, 3Rheumatology Department, Strasbourg University Hospital, Strasbourg, France, 4JSS Medical Research, Saint-Laurent, QC, Canada, 5Immunology, Janssen MEA, Dubai, United Arab Emirates, 6Janssen Cilag Medical Affairs, Issy les Moulineaux, France, 7Laboratoire Interdisciplinaire en études culturelles (LinCS), Strasbourg, France

    Background/Purpose: Patients (pts) with psoriasis (PsO) or PsA are at increased risk for developing gout; and hyperuricemia (HU) prevalence is higher in PsO/PsA pts than…
  • Abstract Number: 2477 • ACR Convergence 2023

    Anifrolumab Normalizes the Type I Interferon Signature in a Cohort of Patients with Type I Interferonopathies

    Sara Alehashemi1, Alexi Baumgardner2, Bita Shakoory3, Adriana Almeida de Jesus2, Sophia Park2, Kat Uss2, Maria P. Robles4, Karin Palmblad5, Annacarine Horne5, Peter Brodin5, Shoghik Akoghlanian6, Roshini Abraham7, Peter Mustillo7, Lilliana Barillas-Arias8, Andrea Heras9, Theresa Wampler Muskardin10, Monica G. Lawrence11, Hannah C. Mannem11, Brian E. Nolan12, Scott Canna13, Adam Reinhardt14, Bryce Binstadt15 and Raphaela Goldbach-Mansky16, 1NIH/NIAID/TADS, Clarksville, MD, 2NIAID, NIH, Bethesda, MD, 3NIH, NIAID, Translational Autoinflammatory Disease Study Unit, Bethesda, MD, 4Indiana University, Indianapolis, IN, 5Karolinska University Hospital, Stockholm, Sweden, 6Nationwide Children's Hospital, Columbus, OH, 7Nationwide Children's Hospital, Columbus, OH, 8Albany Medical Center, Albany, NY, 9Weill Cornell Medicine, New York, NY, 10Hospital for Special Surgery, New York, NY, 11University of Virginia, Charlottesville, VA, 12Lurie Children’s Hospital, Chicago, IL, 13Children's Hospital of Philadelphia, Philadelphia, PA, 14Boys Town National Research Hospital, Omaha, NE, 15University of Minnesota, Minneapolis, MN, 16NIH/NIAID, Potomac, MD

    Background/Purpose: Autoinflammatory Type I Interferonopathies (IFNopathies) include SAVI (STING-associated vasculopathy with onset in infancy), CANDLE/PRASS (Chronic atypical neutrophilic dermatosis, with lipodystrophy and elevated temperature), and…
  • Abstract Number: 2505 • ACR Convergence 2023

    Discovery of First-in-Class IRAK4 Scaffolding Inhibitors for the Treatment of Inflammatory Disorders

    Kate Byth1, Rodney Morgan2, Pierre Michelys3, Kellie Demock2, Geetha Kannan2, Qing Chen1, Brian Sanchez2, Xiaokang Lu2, Alissa Telling2, Chuck Lesch2, Carmen Yu2, Sarah Bradley2, Brian Andresen1, Sherif Hassanien2, Clarke Taylor2, Zhilin Hou2, Ken Borrelli1, Anna Gardberg1, Erika Munschy1, Adam Schwaid1, Anthony Opipari2, Shifeng Pan3 and Luigi Franchi2, 1Odyssey Therapeutics, Boston, MA, 2Odyssey Therapeutics, Ann Arbor, MI, 3Odyssey Therapeutics, San Diego, CA

    Background/Purpose: Interleukin-1 receptor-associated kinase 4 (IRAK4), is a key node that mediates inflammatory signaling in response to activation of toll-like receptor (TLR) and IL-1 receptor…
  • Abstract Number: 2525 • ACR Convergence 2023

    Comparing Patellar Tendon Characteristics Between Adults with and Without Knee Pain

    Samantha Price1, Karin Silbernagel2, David Felson3, Joshua Stefanik4 and Patrick Corrigan1, 1Saint Louis University, St. Louis, MO, 2University of Delaware, Avondale, PA, 3Boston University, Boston, MA, 4Northeastern University, Boston, MA

    Background/Purpose: Knee pain is one of the most common types of joint pain leading to disability, limited physical activity, and reduced quality of life. While…
  • Abstract Number: 2563 • ACR Convergence 2023

    Causal Associations Between Gut Microbiota and Rheumatic Diseases: A Mendelian Randomization Study

    Ying Hu1, Hongyi He2, Yuqing Zhang3, Houchen Lyu4, Chao Zeng2, Jie Wei5 and Guanghua Lei2, 1Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China, 2Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China, 3Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 4Chinese PLA General Hospital, Department of Orthopedics, Beijing, China, 5Health Management Center, Xiangya Hospital Central South University, Changsha, China

    Background/Purpose: Gut microbiota has been increasingly recognized as important and novel targets for rheumatic diseases. However, previous studies mostly examined the associations, leaving causality largely…
  • Abstract Number: 2600 • ACR Convergence 2023

    Clonal Hematopoiesis Is Associated with Giant Cell Arteritis

    Background/Purpose: Giant cell arteritis (GCA) is an age-related vasculitis of large and medium vessels. Prior population studies have identified an association between GCA and hematologic…
  • Abstract Number: PP14 • ACR Convergence 2023

    Putting Lived Experience into Action: Flipping the Script on Living with a Chronic Disease

    Natasha Trehan1 and Naomi Abrahams2, 1University of Ottawa, Take a Pain Check Foundation, Toronto, ON, Canada, 2University of Ottawa, Ottawa, ON, Canada

    Background/Purpose: Naomi was diagnosed with Juvenile Idiopathic Arthritis (JIA) at the age of 18, after enduring 3 years of misdiagnoses. Similarly, Natasha received a diagnosis…
  • Abstract Number: 0089 • ACR Convergence 2022

    Racial Disparities in Rheumatology Clinical Trials

    Pushti Khandwala1, Anila Hussain2 and Irene Tan3, 1Einstein Medical Center Philadelphia, Glen Mills, PA, 2Crozer Chester Medical Center, Glen Mills, PA, 3Einstein Medical Center Philadelphia, Philadelphia, PA

    Background/Purpose: Healthcare disparities exist in patients living with rheumatologic diseases. Factors contributing to disparities include age, sex, race, or sociodemographic variables, each playing a crucial…
  • Abstract Number: 0118 • ACR Convergence 2022

    Sex-Based Variations in Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions

    Cheryl Barnabe1, Patrick McLane2, Nadia Luca1, Katie Lin1, Kelsey Chomistek1, Meghan Elliott1, Shanon McQuitty3, Eileen Davidson3, Clare Hildebrandt4, Steven Katz2, Brian Holroyd2 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Patient and Family Advisors, Alberta Health Services, Calgary, AB, Canada

    Background/Purpose: High quality ambulatory care provision should mitigate avoidable emergency department (ED) visits by persons with inflammatory arthritis (IA) conditions and address the unique realities…
  • Abstract Number: 0119 • ACR Convergence 2022

    Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions Varies by Geographic Location of Residence

    Cheryl Barnabe1, Patrick McLane2, Nadia Luca1, Kelsey Chomistek1, Meghan Elliott1, Shanon McQuitty3, Steven Katz2, Eileen Davidson3, Clare Hildebrandt4, Katie Lin1, Brian Holroyd2 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Patient and Family Advisors, Alberta Health Services, Calgary, AB, Canada

    Background/Purpose: Rheumatology services in Canada are largely restricted to urban centres, resulting in significant access difficulties for residents of rural and remote locations. As a…
  • Abstract Number: 0126 • ACR Convergence 2022

    Should Arthrocentesis Be Attempted in the Symptomatic but Non-Effusive Knee?

    Rosemina Patel1, Angie Ariza-hutchinson1, Ahsan Iqbal1, Matthew McElwee1, N. Suzanne Emil1, Sharon Nunez1, maheshwari muruganandam1, frank O'Sullivan1, Roderick Fields1, Yvonne Waters2 and Wilmer Sibbitt1, 1University of New Mexico, Albuquerque, NM, 2University of New Mexico Hospital, Corrales, NM

    Background/Purpose: Arthrocentesis of the painful but non-effusive knee is usually not undertaken due to a high arthrocentesis failure rate. We hypothesized that compression-assisted arthrocentesis of…
  • Abstract Number: 0236 • ACR Convergence 2022

    What Ultrasound Skills Can Be Learned Before Laying Hands on a Probe? Results of a Pilot Study of a Hybrid Online and in Person Curriculum to Teach Rheumatology Focused Knee Ultrasonography Skills to Internal Medicine Residents

    Andrew Long1, Norman Madsen2, William Novak1, Homaira Rahimi3 and Bethany Marston3, 1University of Rochester Medical Center, Rochester, NY, 2University of Rochester, NY, Rochester, NY, 3University of Rochester, Rochester, NY

    Background/Purpose: Developing competence in musculoskeletal point of care ultrasound (MSK POCUS) involves mastery of 3 key domains: image acquisition, image interpretation, and incorporation of findings…
  • Abstract Number: 0743 • ACR Convergence 2022

    Home-Based Telehealth in Rheumatology: A Systematic Review & Narrative Synthesis

    Alexander Peck1, Rebecca Grainger2, Jeffrey Curtis3, John Cush4, Neelkamal Soares5, Nikhil Davuluri6, William Benjamin Nowell7, Sandeep Sodhi8, Danielle Grauer8, Natalie Fortune6, Shilpa Venkatachalam9, Daniel Kirby10, Jeffrey Alper11, Kelly Gavigan12, Laura Stradford7, David Curtis12 and Swamy Venuturupalli1, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2University of Otago, Wellington, New Zealand, 3Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 4RheumNow, Dallas, TX, 5Western Michigan University, Kalamazoo, MI, 6Attune Health, Beverly HIlls, CA, 7Global Healthy Living Foundation, Nyack, NY, 8Illumination Health, Birmingham, AL, 9Global Healthy Living Foundation, New York, NY, 10Bendcare, Charlotte, NC, 11Bendcare, Naples, 12Global Healthy Living Foundation, Upper Nyack, NY

    Background/Purpose: Home based telehealth (HBT) visits, where a patient is located at home with a remote provider, became common during the COVID-19 pandemic. Patients now…
  • Abstract Number: 0973 • ACR Convergence 2022

    Assessing Musculoskeletal Health Needs of Underserved Patients & Community Members Using a Community Based Participatory Research Approach

    Titilayo Adeniran, Bertilia Trieu, Sandra Goldsmith and Laura Robbins, Hospital for Special Surgery, New York, NY

    Background/Purpose: Musculoskeletal disorders are the most prevalent health conditions in the U.S. resulting in financial and social burdens, especially in underserved communities. There are also…
  • Abstract Number: 1006 • ACR Convergence 2022

    Impact of Uric Acid Levels on Clinical and Radiographic Characteristics in Psoriatic Arthritis and Response to Secukinumab: A Pooled “Post Hoc” Analysis from Five Phase 3 Studies

    Renaud FELTEN1, Laura Widawski2, Lionel Spielmann2, Corine Gaillez3, Weibin Bao4, Hugh O’Neill5, jacques-eric gottenberg6, Pierre-Marie Duret2 and Laurent Messer7, 1Hôpitaux Universitaires de Strasbourg, Strasbourg, France, 2Colmar Civilian Hospitals, Colmar, France, 3Novartis Pharma AG, Basel, Switzerland, 4Novartis Pharmaceuticals Corporation, East Hanover, NJ, 5Novartis Ireland Limited, Dublin, Ireland, 6Strasbourg University Hospital, Strasbourg, France, 7Colmar Civil Hospitals, Colmar, France

    Background/Purpose: Hyperuricemia (HU), a common metabolic abnormality, may result in development of gout, which is an inflammatory arthritic condition1,2. Patients (pts) with psoriasis (PsO)/psoriatic arthritis…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 96
  • Next Page »
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology